dna. 23andme
Google diagnostic firm receives scathing FDA warning
November 26, 2013Medical Communications, Research and Development, Sales and Marketing FDA, dna. 23andme, google
The Google-backed DNA testing firm 23andMe has received a warning letter from the FDA saying it cannot continue to market …
Latest content
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
